Ask Michael Burke Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Knighty Tin who wrote (78181)	3/20/2000 5:27:00 PM
From: gnuman	Read Replies (1) of 132070

MB, This may be why vaso is down. GENERX is a non-surgically administered gene therapy designed to stimulate angiogenesis (new blood vessel growth), providing an alternate route for blood to flow around blocked or clogged arteries. Envisioned as an out-patient procedure that could be administered by cardiologists, GENERX involves a one-time, non-surgical administration of an adenoviral gene therapy vector containing the human Fibroblast Growth Factor-4 (FGF-4) angiogenic gene delivered into the coronary arteries through a standard catheter. Apparently provides the same type results as vaso treatments. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next